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Depending on their stage of diff  erentiation, 
mature T cells require contact with peptide/
MHC complexes and/or cytokines, most nota-
bly the common γ chain (γc) cytokines IL-7 
and IL-15 (1–4). Naive CD4+ T cells show 
low expression of CD44, and these CD44lo cells 
are controlled by IL-7 and possibly MHC-II 
molecules, although the importance of the 
  latter is controversial (5–7). The factors con-
trolling naturally occurring memory phenotype 
(MP) CD44hi CD4+ are not well character-
ized, although antigen-specifi  c memory CD4+ 
cells are known to be sustained by IL-7 and, to 
a lesser extent, IL-15 (8–10). For CD8+ cells, 
naive CD44lo cells are maintained by IL-7 and 
MHC-I molecules (5, 11, 12), whereas MP 
and antigen-specifi   c memory cells are con-
trolled by IL-15 and IL-7 and do not require 
contact with MHC-I complexes (13–16).
For naive T cells, TCR contact with for-
eign antigen causes CD44lo cells to convert to 
CD44hi cells and show transient up-regulation 
of several surface markers, including IL-2Rα 
(CD25), CD69, and CD43 (1–4). Many of the 
responding cells also show decreased levels 
of CD62L (L-selectin) and IL-7Rα (CD127). 
Interestingly, naive T cells normally maintain 
a resting (CD25lo, CD69lo, CD43lo, CD62Lhi, 
CD127hi) phenotype despite continuous TCR 
contact with self-MHC ligands, implying that 
this form of TCR–MHC interaction delivers 
only a weak signal, adequate for maintaining 
cell viability but insuffi   cient for overt stimula-
tion and subsequent proliferation. Except for 
their CD44hi phenotype, MP CD8+ cells show 
a similar pattern of cell surface markers as naive 
CD8+ cells, with the exception that  60–70% 
of MP CD8+ cells display high levels of the 
IL-2/IL-15Rβ chain (CD122). This receptor 
chain is crucially important for controlling sen-
sitivity to IL-15 (13, 17). Thus, CD122hi MP 
CD8+ cells are overrepresented in IL-15 trans-
genic (tg) mice (18, 19). Conversely, IL-15–/– 
(13, 20) and IL-15Rα–/– (21) mice show a 
marked and selective reduction of CD122hi 
MP CD8+ cells. This subset of MP CD8+ cells 
is highly dependent on IL-15 for IFN-induced 
bystander proliferation as well as for normal 
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“background” proliferation (turnover) and survival (13). In 
marked contrast, the remaining  30–40% of MP CD8+ cells 
are CD122lo and IL-15 independent. As a consequence, 
CD122lo MP CD8+ cells account for nearly all of the re-
maining MP CD8+ cells in IL-15–/– mice. These cells are 
unaff  ected by IFN-induced (IL-15–mediated) bystander pro-
liferation and survive well upon adoptive transfer to IL-15–/– 
mice (13). We decided to investigate the factor(s) responsible 
for the survival and turnover of the CD122lo subset of MP 
CD8+ cells.
Here, we demonstrate that the majority of CD122lo MP 
CD8+ cells are a unique population with the phenotype of 
activated cells. These cells account for most of the residual 
CD8+ cells in γc
–/– mice, implying lack of dependence on γc 
cytokines (IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21) for their 
survival and turnover. Signifi  cantly, CD122lo MP CD8+ cells 
disappear rapidly and cease to proliferate upon transfer to 
MHC-I–/– hosts. Hence, unlike typical IL-15–dependent 
CD122hi cells, the CD122lo subset of MP CD8+ cells is 
largely cytokine independent and kept alive through contin-
uous TCR contact with MHC-I ligands.
RESULTS
Phenotypic features of MP CD8+ subsets
Normal animals accumulate CD44hi MP CD4+ and CD8+ 
cells with increasing age, presumably as a result of lifetime 
exposure to various environmental antigens or self-antigens. 
In young (2–3-mo-old) C57BL/6 (B6) mice, MP T cells ac-
count for  10% of the T cells in the LN and  15% of splenic 
T cells (Fig. 1 A). Although CD44 levels are comparable on 
MP CD4+ and MP CD8+ cells, expression of the IL-2/IL-
15Rβ receptor (CD122) is considerably higher on MP CD8+ 
than MP CD4+ cells, as described previously (13, 17). Thus, 
plotting CD44 against CD122 divides CD8+ cells into three 
subsets: CD122lo CD44lo (naive), CD122lo CD44hi MP, and 
CD122hi CD44hi MP cells.
The majority of MP CD8+ cells ( 60–70%) carries high 
levels of CD122 (Fig. 1 A). Staining for other surface markers 
showed that CD122hi MP CD8+ cells were quite similar to 
naive CD44lo CD8+ cells for several markers; thus, both sub-
sets consisted almost exclusively of resting T cells character-
ized by a CD25lo, CD43lo, CD62Lhi, CD69lo, and CD127hi 
phenotype (Fig. 1 B). As shown previously for total MP 
CD8+ cells (22), CD122hi MP CD8+ cells diff  ered from na-
ive CD44lo cells in showing a signifi  cant but slow tempo of 
proliferation, as measured by incorporation of the DNA pre-
cursor BrdU given for 3 or 7 d (Fig. 1 C). Note that prolifer-
ation of CD44lo cells is restricted to BrdUintermediate cells, 
which are recent thymic emigrants that incorporated a low 
level of BrdU in the thymus before export (22). Despite their 
similar surface markers, CD122hi MP CD8+ cells and naive 
CD8+ cells were clearly diff  erent with regard to Bcl-2 ex-
pression and IFN-γ production. Thus, relative to naive 
CD8+ cells, CD122hi MP CD8+ cells showed two- to three-
fold higher levels of Bcl-2 (Fig. 1 D) and >10-fold higher 
production of IFN-γ upon in vitro stimulation (Fig. 1 E).
The properties of the CD122lo subset of CD8+ MP cells 
were quite diff  erent. Thus, these cells diff  ered from the other 
two CD8+ subsets in that they were enriched for partly acti-
vated cells with a CD43hi, CD62Llo, CD69hi, CD127lo pheno-
type (Fig. 1 B), thereby resembling TCR-activated T cells 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20052495/DC1). CD122lo MP cells also showed low 
levels of Bcl-2 (Fig. 1 D). However, unlike overtly activated 
T cells stimulated by strong TCR ligation, the levels of CD25 
(IL-2Rα) and CD132 (γc) on CD122lo MP CD8+ cells were 
not elevated (relative to resting T cells). In line with their ex-
pression of activation markers, CD122lo MP CD8+ cells di-
vided two to three times faster than the CD122hi MP CD8+ 
subset (Fig. 1 C). Also, CD122lo CD44hi CD8+ cells  produced 
Figure 1.  Features of MP CD8+ subsets. Spleen and pooled LN cells 
from 2–3-mo-old normal B6 mice were stained and analyzed by fl  ow 
cytometry for (A) CD44 and CD122 expression in CD4+ or CD8+ cells, 
(B) surface expression of CD25 (IL-2Rα), CD132 (γc), CD43 (1B11), CD62L 
(L-selectin), CD69, and CD127 (IL-7Rα) in CD8+ T cell subsets, (C) BrdU 
incorporation of CD8+ T cell subsets after 3 or 7 d of BrdU in the drinking 
water, or (D) intracellular levels of Bcl-2 (solid line) versus isotype-
matched control mAb (shaded area) in CD8+ T cell subsets. Numbers 
  indicate percentages of gated cells for histograms in A and C, cells in 
quadrants for dot plots in A, or mean fluorescence intensity of Bcl-2 
staining in D. The data are representative of at least three different 
  experiments. (E) CD8+ T cell subsets were purifi  ed by fl  ow cytometry and 
stimulated in vitro with PMA and ionomycin for 4 h. Culture supernatants 
were then collected and assayed by ELISA for IFN-γ. The mean IFN-γ 
  concentrations (plus one standard deviation) are shown. The data are 
representative of two different experiments.JEM VOL. 203, July 10, 2006  1819
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twofold less IFN-γ than the CD122hi subset of MP CD8+ 
cells (Fig. 1 E), suggestive of partial anergy.
Collectively, the data described above indicate that MP 
CD8+ cells can be divided into resting CD122hi cells and 
partly activated CD122lo cells. Nevertheless, some of the 
CD122lo cells seemed to be resting cells. The origin of these 
latter cells is discussed below.
Adoptive transfer of CD8+ cell subsets to normal B6 mice
The properties of the activated CD122lo subset of MP CD8+ 
cells suggested that these cells could be a short-lived popula-
tion. To investigate this possibility, we purifi  ed CD8+ cell 
subsets by FACS. The purity of the CD8+ subsets after sort-
ing was usually >99% for CD44lo cells and CD122hi CD44hi 
cells, and 88–90% for the CD122lo CD44hi subset (Fig. 2 A). 
The sorted CD8+ subsets were prepared from Thy1.1 con-
genic mice and adoptively transferred i.v. to normal young 
B6 mice (Thy1.2). The host mice were killed 7 d later to an-
alyze LN and spleen cells by fl  ow cytometry. The transferred 
CD44lo CD8+ cells accumulated preferentially in host LN, 
and most (>96%) of the cells maintained low levels of CD44, 
thus maintaining their naive phenotype (Fig. 2 B). The trans-
ferred CD122hi MP CD8+ cells homed equally well to the 
LN and spleen. Interestingly, the cells recovered from host 
LN were >95% CD122hi, whereas  30% of the cells from 
the spleen were CD122lo cells, suggestive of CD122 down-
regulation (see below). These latter CD122lo cells maintained 
their CD62Lhi phenotype (Fig. 2 C) and did not express the 
activation markers discussed above (not depicted).
The transferred CD44hi CD122lo CD8+ cells behaved 
diff  erently. These cells homed preferentially to the spleen and 
a considerable fraction partly up-regulated CD122, both in 
the LN and spleen. As seen above for BrdU incorporation, 
the transferred MP CD122lo CD8+ cells proliferated consid-
erably, yielding two- to threefold higher cell recoveries than 
for transferred CD122hi MP cells or CD44lo cells, especially 
in the spleen (Fig. 2, B and D). Like the initially injected 
cells, many of the recovered cells maintained a CD62Llo phe-
notype (Fig. 2 C), contrasting with the CD122lo cells derived 
from the transferred MP CD122hi CD8+ cells that were 
purely CD62Lhi. Upon CD122 up-regulation, however, the 
transferred CD44hi CD122lo CD8+ cells became predomi-
nantly CD62Lhi (Fig. 2 C).
Therefore, the transfer experiments described above 
suggest that the CD122lo subset of MP CD8+ cells con-
sists of a mixture of (a) partly activated cells and (b) resting 
MP cells that down-regulated their CD122 levels, perhaps 
in response to IL-15. In favor of this idea, brief ( 4 h) 
exposure of normal CD8+ cells to IL-15 in vitro at 37°C 
caused CD122hi cells to revert to CD122lo cells while re-
maining CD62Lhi (Fig. S2, available at http://www.jem.
org/cgi/content/full/jem.20052495/DC1).
CD8+ cell subsets in 𝗄c
–/– mice
As mentioned above, MP CD8+ cells in IL-15–/– and IL-
15Rα–/– mice are nearly all CD122lo cells (13, 20, 21, and 
unpublished data). Interestingly, the few CD8+ cells pres-
ent in γc
–/– mice proved to be CD122lo cells (Fig. 3 A). 
These cells comprised a relatively homogeneous population 
with high intermediate expression of CD44 and low inter-
mediate expression of CD122. Like MP CD8+ cells from 
Figure 2.  Phenotype of MP CD8+ cells on adoptive transfer. 
(A) Thy1.1-marked pooled LN cells from normal B6 mice were sorted by fl  ow 
cytometry for CD44lo versus CD44hi CD122lo versus CD44hi CD122hi CD8+ 
T cells, resulting in the indicated purities after the sort. Sorted CD8+ T cell 
subsets were then transferred i.v. at 1.5 × 106 cells/mouse to Thy1.2-
marked WT mice, recovered 7 d later from pooled LN and spleen cells, 
and stained for FACS analysis. Transferred donor cells, identifi  ed as CD8+ 
Thy1.1+ cells, were examined for (B and C, left) CD44 versus CD122 and 
CD62L expression levels in CD44hi CD122lo (C, middle) versus CD44hi 
CD122hi donor CD8+ cells (C, right). The CD44/CD122 gates were set ac-
cording to host CD8+ cells in the same staining as shown. Numbers indi-
cate percentages of cells in quadrants. (D) Total donor cell numbers (plus 
one standard deviation) were calculated for mice in B. The data show total 
numbers of donor-derived T cells recovered from the spleens and pooled 
LNs of host mice (two mice/group) after injection of purifi  ed donor CD44lo, 
CD44hi CD122hi, and CD44hi CD122lo CD8+ cells. The data are representa-
tive of at least two separate experiments.1820  MHC-I–DEPENDENT MEMORY PHENOTYPE CD8+ SUBSET | Boyman et al.
IL-15–/– mice, γc
–/– CD8+ cells were enriched for activa-
tion markers (Fig. 3 C and not depicted) and had a rapid 
turnover (Fig. 3 D).
These fi  ndings with γc
–/– CD8+ cells suggested that the 
CD122lo MP CD8+ cells in normal mice may be indepen-
dent of γc cytokines. If so, raising the level of γc cytokines 
would be expected to expand only the CD122hi and not the 
CD122lo subset of CD8+ cells. In line with this prediction, 
CD122lo cells comprised only a small proportion of MP 
CD8+ cells in mice expressing high levels of γc cytokines, 
namely IL-7 tg mice (Fig. 3 B; reference 14). In these mice, 
 90% of MP CD8+ cells were CD122hi cells with a resting 
phenotype and slow turnover (Fig. 3 D and not depicted).
The enrichment of activated CD122lo MP CD8+ cells in 
IL-15–/– and γc
–/– mice raised the possibility that these cells 
were not maintained by cytokines but by other stimuli, per-
haps TCR interactions with MHC-I ligands. Indirect sup-
port for this possibility came from the fi  nding  that 
MHC-I–/– mice were virtually devoid of CD122lo MP CD8+ 
cells (Fig. 3 A). These mice contained MP CD8+ cells, pre-
sumably selected by MHC-Ib molecules (23), but these cells 
consisted almost entirely of CD122hi cells with a resting phe-
notype and slow turnover (Fig. 3, C and D).
Transfer of CD122–/– MP CD8+ cells to MHC-I–/– hosts
Collectively, the data described above suggest that γc cyto-
kines are not essential for survival or background turnover of 
CD122lo CD44hi CD8+ cells and that these cells might be 
maintained and stimulated through contact with MHC-I 
ligands. To examine this possibility directly, we transferred 
cells to MHC-I–/– hosts. In initial experiments, CD8+ cells 
were prepared from CD122–/– mice. These mice contain large 
numbers of CD8+ cells, most (>70%) of which express acti-
vation markers and have a rapid turnover (Fig. S3, available 
at http://www.jem.org/cgi/content/full/jem.20052495/DC1). 
By these parameters and being CD122–/–, the cells closely 
  resemble the CD122lo subset of MP CD8+ cells in nor-
mal mice. To test whether these cells are MHC-I depen-
dent, purifi  ed total T cells from CD122–/– mice were labeled 
with CFSE and adoptively transferred to sublethally irradi-
ated (750 cGy) WT versus MHC-I–/– mice. Irradiation of the 
hosts was necessary to reduce rejection of the transferred cells 
by the residual MP CD8+ cells in the MHC-I–/– recipients. 
By 7 d after cell transfer, the donor CD4+ T cells had prolif-
erated comparably well in WT and MHC-I–/– hosts as shown 
by CFSE dilution (Fig. 4 A). In marked contrast, the donor 
CD8+ T cells proliferated well in the WT mice but showed 
almost no division in MHC-I–/– recipients, resulting in 10-
fold reduced cell recoveries from MHC-I–/– hosts compared 
with WT recipients (Fig. 4, A and B).
For the WT hosts, some of the proliferating donor CD8+ 
cells might be derived from contaminating naive cells, which 
can undergo MHC-I–dependent lymphopenia-induced pro-
liferation. Therefore, we prepared purifi  ed (99%) CD44hi T 
cells from CD122–/– mice and adoptively transferred these 
cells to irradiated WT versus MHC-I–/– mice. Again, 7 d 
  after adoptive transfer, the donor CD4+ T cells showed com-
parable division profi  les in both groups as shown by CFSE 
dilution, whereas the donor CD8+ T cells proliferated much 
less in MHC-I–/– recipients than in WT hosts (Fig. 4 C). This 
diff  erence was also seen when the transferred cells were en-
riched for CD44hi T cells ( 90%) by magnetic cell sorting 
(Fig. 4 D). In contrast to these experiments using T cells from 
CD122–/– mice, when sorted CD44hi T cells from normal B6 
WT mice were used as donor cells, the donor CD8+ T cells 
proliferated equally well in both hosts (Fig. 4 E), demonstrat-
ing that CD122hi MP CD8+ cells expand in an MHC-I–
  independent fashion (24).
Thus, these experiments show that proliferation of 
CD122–/– CD44hi CD8+ cells is heavily dependent on con-
tact with MHC-I molecules.
Transfer of normal MP CD8+ cells to MHC-I–/– hosts
Despite their similar phenotype, MP CD8+ cells from 
CD122–/– mice might not necessarily be equivalent to the 
CD122lo subset of MP CD8+ cells in normal mice. Hence, 
it remained important to test the MHC-I dependency of 
normal CD122lo MP CD8+ cells. Therefore, the experi-
ments described above were repeated with purifi  ed MP CD8+ 
cells prepared from normal B6 mice. Rather than injecting 
purifi  ed  CD122lo MP CD8+ cells, which are diffi   cult  to 
  prepare in more than minimal numbers from normal mice 
(Fig. 2), we transferred purifi  ed normal B6 MP CD8+ cells 
Figure 3.  MP CD8+ subsets in 𝗄c
–/– and MHC-I–/– mice. Spleen cells 
from age- and gender-matched (A) WT, γc
–/–, or MHC-I–/– mice, or (B) WT 
and IL-7 tg mice (all on a B6 background) were stained for CD3, CD8α, 
CD44, and CD122 and analyzed by fl  ow cytometry for CD44 and CD122 
expression levels on CD8+ T cells. The CD8+ cells in MHC-I–/– mice were 
additionally stained for CD8β and TCRβ to confi  rm that these cells were 
CD8αβ+ TCRαβ+ cells. Numbers indicate percentages of cells in quad-
rants. (C) Spleen cells from the indicated mice were stained for CD3, CD8, 
CD62L, CD43 (top) or CD3, CD8, CD69, and CD43 (bottom) and analyzed 
by flow cytometry. The data show staining of gated CD3+ CD8+ cells. 
(D) The indicated mice were given BrdU in the drinking water for 3 d before 
being killed and intracellular BrdU staining. Shown are the percentages of 
BrdU+ cells in CD44hi CD122lo or CD44hi CD122hi CD8+ T cells. The data 
are representative of at least two different experiments.JEM VOL. 203, July 10, 2006  1821
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(i.e., a mixture of CD122lo CD44hi and CD122hi CD44hi 
cells) to irradiated WT versus MHC-I–/– hosts (Fig. 5 A). When 
the injected cells were recovered 1 wk later, a high proportion 
of the donor CD44hi cells (90%) were CD122hi, presumably 
refl  ecting homeostatic expansion of these latter cells in re-
sponse to the raised levels of γc cytokines in the lymphopenic 
environment of the irradiated hosts (14). The few donor 
CD122lo cells in the WT hosts were enriched for cells with 
an activated CD62Llo CD43hi phenotype, consistent with 
chronic activation to MHC-I ligands (Fig. 5 B). Signifi  cantly, 
cells with this activated phenotype were quite rare in the 
MHC-I–/– hosts. In these hosts, the donor MP CD8+ cells 
were enriched for CD122hi cells and the minor subset of do-
nor CD122lo cells had a resting CD62Lhi CD43lo phenotype, 
consistent with these cells being revertants from CD122hi 
cells (Fig. 5 B). In terms of cell numbers, total numbers of 
CD62Llo and CD43hi subsets of donor CD44hi CD122lo 
CD8+ cells were greatly reduced in MHC-I–/– hosts; i.e., by 
fi  vefold and eightfold, respectively (Fig. 5 C). In contrast, 
  total numbers of donor CD122hi cells in WT and MHC-I–/– 
hosts were comparable (Fig. 5 D).
The above fi  ndings indicated that as for CD8+ cells from 
CD122–/– mice, the subset of activated CD122lo MP CD8+ 
cells in normal mice disappeared rapidly after transfer to 
MHC-I–/– hosts. 
Transfer to nonirradiated MHC-I–/– hosts
A complicating feature of the experiments described above is 
that irradiation of the hosts to prevent rejection caused the 
donor cells to undergo lymphopenia-induced homeostatic 
proliferation. Hence, it was important to have comparable 
information on cell survival in nonirradiated MHC-I–/– hosts. 
Here, the main problem is rejection by residual host CD8+ 
cells. Because rejection by MHC-I–/– hosts is directed to 
MHC-I molecules on the donor cells, we avoided the prob-
lem of rejection by preparing donor cells that lacked MHC-I; 
i.e., by reconstituting heavily irradiated normal B6 WT mice 
Figure 4.  Fate of CD122–/– T cells transferred to irradiated MHC-I–/– 
hosts. Irradiated WT versus MHC-I–/– hosts were injected i.v. with (A–D) 
CFSE-labeled T cells (2–3 × 106 cells/mouse) from CD122–/– mice or 
(E) purifi  ed and CFSE-labeled CD44hi T cells (2–3 × 106 cells/mouse) from 
normal B6 WT mice. The cells transferred were (A and B) unseparated 
CD122–/– T cells prepared by complement-mediated killing with mAbs, 
(C) FACS-sorted CD44hi CD122–/– T cells, (D) CD8+ CD122–/– cells enriched 
for CD44hi cells by magnetic bead separation, or (E) FACS-sorted CD44hi 
T cells from normal B6 WT mice. The host mice received (A, B, and E) 
a single dose of 750 cGy or (C and D) two doses of 600 cGy 2 wk apart. 
CFSE dilution of the cells recovered from host spleen was examined 7 d 
later. Histograms show CFSEhi CD4+ or CD8+ donor cells, respectively. 
Numbers indicate percentages of cells in quadrants. (B) Total cell numbers 
(plus one standard deviation) of donor CD4+ and CD8+ T cells recovered 
from the spleens and pooled LNs of WT (filled bars) versus MHC-I–/– 
(open bars) hosts treated as in A (two mice/group). Numbers above the 
bars indicate the ratios of total cells from WT versus MHC-I–/– hosts. 
p-values of WT compared with MHC-I–/– cell numbers were calculated 
using a paired t test. *, not signifi  cant (P = 0.4); **, signifi  cant (P = 0.02). 
The data are representative of at least two different experiments. 
Figure 5.  Fate of normal B6 MP T cells transferred to irradiated 
MHC-I–/– hosts. Purifi  ed CD44hi T cells from Thy1.1-marked normal B6 
WT mice were transferred i.v. at 1.5 × 106 cells/mouse to irradiated
 (750 cGy) Thy1.2-marked WT or MHC-I–/– mice. 7 d after transfer, mice 
were killed and analyzed by fl  ow cytometry for donor (Thy1.1+) CD8+ 
and CD4+ cells (A), and for CD62L and CD43 expression on donor CD122lo 
CD44hi CD8+ (B, left two columns) versus CD122hi CD44hi CD8+ cells 
(B, right two columns). Total numbers of donor CD44hi CD8+ T cells were 
calculated and are shown for (C) CD122lo CD62Llo and CD122lo CD43hi 
cells, and (D) CD122hi CD62Lhi CD43lo cells (resting CD122hi cells) recov-
ered from the spleens and pooled LNs of WT (fi  lled bars) versus MHC-I–/– 
(open bars) hosts. Numbers above the bars indicate the ratios of total cells 
from WT versus MHC-I–/– hosts. The data are representative of at least two 
separate experiments.1822  MHC-I–DEPENDENT MEMORY PHENOTYPE CD8+ SUBSET | Boyman et al.
with BM cells from MHC-I–/– mice (25). The MHC-I–/– 
CD4+ and CD8+ cells generated in these MHC-I–/–→WT 
chimeras closely resembled the cells generated in control 
WT→WT chimeras (Fig. 6 A). In contrast, CD4+ cells, but 
very few CD8+ cells, were generated in reciprocal WT→
MHC-I–/– and MHC-I–/–→MHC-I–/– chimeras.
For adoptive transfer experiments, we used purifi  ed do-
nor Thy1-marked T cells from MHC-I–/– (Thy1.1)→WT 
(Thy1.2) chimeras. These MHC-I–/– T cells, a mixture of 
CD4+ and CD8+ cells, were then transferred to WT versus 
MHC-I–/– mice (both Thy1.2). To avoid rejection by NK 
cells, the hosts had been pretreated with anti-NK1.1 mAb. 
With transfer to WT hosts, the phenotype of the donor MP 
CD8+ cells remained constant and there was no decline in 
the proportion of CD122lo cells (Fig. 6 B). With transfer to 
MHC-I–/– hosts, in contrast, the proportion of CD122lo MP 
CD8+ cells declined abruptly between days 1 and 14 after 
transfer, leading to a reciprocal relative increase in CD122hi 
cells (Fig. 6 C). This decrease in CD122lo MP CD8+ donor 
cells was also evident from total cell recoveries after adoptive 
transfer. Thus, for the donor MP CD8+ cells, the total recov-
ery of CD122hi cells was the same in WT and MHC-I–/– hosts 
on day 14, whereas the recovery of CD122lo cells was four-
fold lower in MHC-I–/– hosts than in WT hosts (Fig. 6 D). 
There was no change in CD4+ cells (not depicted).
Collectively, the above three sets of experiments with 
MHC-I–/– hosts indicate that the subset of MP CD8+ cells 
with an activated CD122lo phenotype is MHC-I dependent 
and is presumably engaged in chronic TCR responses to 
MHC-I ligands.
DISCUSSION
As mentioned earlier, T cells exhibiting the properties and 
features of antigen-specifi  c memory cells arise early in life and 
become a dominant population in old age. The prevailing 
view is that these naturally occurring MP T cells are the 
progeny of naive precursors responding to various environ-
mental antigens. However, some MP T cells may arise 
through contact with self-antigens rather than foreign antigens. 
This possibility is supported by the fi  nding that naive T cells 
undergo “homeostatic” proliferation and diff  erentiation into 
typical MP cells during T lymphopenia, e.g., in the normal 
neonatal period or when adult mice are depleted of T cells 
(26–28). This proliferative response is directed largely to self-
antigens and is stimulated by the raised levels of γc cytokines, 
especially IL-7, that occur when total T cell levels are low. 
What proportion of MP cells are driven by self-rather than 
foreign antigens in normal mice is unclear. Nevertheless, it is 
notable that MP cells are readily detectable in germ-free mice 
and even in “antigen-free” mice fed an amino acid diet 
(29, 30, 31 and unpublished data). Thus, most MP cells may 
be the progeny of self-reactive cells. Characterizing the fea-
tures of MP cells is therefore important.
For MP CD8+ cells, we show here that these cells com-
prise two broad subsets: (a) a major population of resting 
CD122hi CD44hi cells and (b) a minor subset of partly activated 
Figure 6.  Fate of MHC-I–/– chimera T cells transferred to non-
irradiated MHC-I–/– hosts. (A) BM chimeras were prepared by transferring 
BM stem cells (BM cells depleted of mature B, T, and MHC-II–expressing 
cells by mAb plus complement) to lethally irradiated (1,300 cGy) Thy1.2-
marked WT or MHC-I–/– mice. The data show representative staining for 
T cell subsets in the spleens of the indicated chimeras at 3–4 mo after 
reconstitution. (B and C) Purifi  ed MHC-I–/– T cells (Thy1.1+) from MHC-I–/–
→WT BM chimeras were adoptively transferred i.v. at 2–3 × 106 cells/
mouse to Thy1.2-marked WT or MHC-I–/– mice, which had been depleted 
of NK cells using anti-NK1.1 mAb (PK136) on days −3 and −1 before 
adoptive transfer and every other day thereafter. On days 1 and 14 after 
adoptive transfer, mice were killed and phenotyped by fl  ow cytometry 
for the presence of donor CD8+ subsets (B), or the percentage of   donor 
CD122lo CD44hi CD8+ cells within total donor CD44hi CD8+ cells was 
  calculated (C). Numbers in A and B indicate percentages of cells in quad-
rants. (D) Total cell numbers (plus one standard deviation) of donor CD44hi 
CD8+ T cells, which were CD122hi (hi) or CD122lo (lo), recovered from the 
spleens and pooled LNs of WT (filled bars) versus MHC-I–/– (open bars) 
hosts from two independent experiments performed as   described in B. 
Numbers above the bars indicate the ratios of cell numbers recovered 
from WT versus MHC-I–/– hosts. p-values of WT compared with MHC-I–/– 
cell numbers were calculated using a paired t test. *, not signifi  cant (P = 0.2); 
**, signifi  cant (P = 0.04).JEM VOL. 203, July 10, 2006  1823
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CD122lo CD44hi cells. The CD122hi subset closely   resembled 
naive CD44lo CD8+ cells by several surface markers but was 
distinct in two respects. First, confi  rming previous fi  ndings 
(13, 22), background proliferation of CD122hi cells was slow 
but signifi  cant; in contrast, naive CD44lo CD8+ cells rarely 
divided. Second, unlike naive CD8+ cells, CD122hi CD8+ 
cells proved to be MHC-I independent. Thus, CD122hi cells 
expanded in MHC-I–/– hosts, whereas naive cells gradually 
disappeared (Fig. 6 and not depicted).
Unlike CD122hi cells, the CD122lo component of MP 
CD8+ cells had a rapid turnover and was enriched in cells 
with activated phenotype. These cells were spread through-
out the secondary lymphoid tissues, including peripheral 
LNs, suggesting the cells were activated by a pervasive rather 
than a local stimulus. As in IL-15–/– mice, CD122lo MP 
CD8+ cells were enriched in γc
–/– mice, indicating a lack of 
dependence on γc cytokines. Although reliance on other cy-
tokines cannot be excluded, the cells are probably maintained 
largely by TCR stimuli. This follows from the fi  nding that 
CD122lo MP CD8+ cells disappeared rapidly and ceased to 
proliferate after transfer to MHC-I–/– hosts. It should be noted 
that a signifi  cant proportion of CD122lo MP CD8+ cells (30–
50%) were MHC-I independent and had a resting pheno-
type. Based on the eff  ects of exposing cells to IL-15 in vitro, 
resting CD122lo MP CD8+ cells are probably “revertants” 
of CD122hi cells responding to IL-15.
A key issue is whether the activated CD122lo subset of 
MP cells can be equated with a subset of antigen-specifi  c 
memory cells. In the case of CD122hi MP CD8+ cells, these 
cells closely resemble typical long-lived, antigen-specifi  c 
“central” memory cells (4) by multiple parameters, including 
surface markers, turnover, IL-15 dependency, and lack of de-
pendence on MHC-I. It might then follow that CD122lo MP 
CD8+ cells are the counterpart of “eff  ector” memory cells. 
This is unlikely for several reasons (32–34). First, despite their 
CD62Llo phenotype, eff  ector memory cells do not display 
activation markers. Second, whereas CD122lo MP CD8+ 
cells have a rapid turnover, eff  ector memory CD8+ cells have 
a slow turnover. Third, in terms of IFN-γ production, 
CD122lo MP cells are anergic, whereas eff  ector memory cells 
respond as eff  ectively as central memory cells. Fourth, unlike 
CD122lo MP cells, eff  ector memory cells are CD122hi cells. 
Fifth, unlike eff  ector memory cells, CD122lo MP CD8+ cells 
are proportionally as frequent in LNs as in the spleen. Hence, 
activated CD122lo MP CD8+ cells cannot be equated with 
either eff  ector or central memory cells.
Although clearly diff  erent from classical memory cells, 
CD122lo MP CD8+ cells closely resemble a population of 
antigen-specifi  c memory CD8+ cells that develops during 
chronic viral infections in mice (35–37). These cells have low 
levels of CD122, IL-7Rα, CD62L, and Bcl-2, express higher 
levels of CD43 as well as CD69, and display partial anergy 
in terms of antigen responsiveness. Signifi  cantly, CD8+ cells 
in chronic infections rapidly disappear when deprived of 
contact with specifi  c antigen, suggesting that the cells are 
maintained largely by chronic TCR contact with persisting 
antigen. Interestingly, CD8+ cells found in HIV-infected in-
dividuals are enriched in cells carrying memory markers as 
well as low levels of IL-7Rα and CD62L, show a higher in 
vivo proliferation rate, and are more susceptible to apoptosis 
and partially anergic in vitro (38). Thus, the memory CD8+ 
cells generated during chronic infection have much in com-
mon with the naturally occurring population of CD122lo MP 
CD8+ cells described here.
The MHC-I ligands recognized by CD122lo MP CD8+ 
cells are unclear. The possibility we favor is that these cells are 
reacting to the same self-ligands that drive homeostatic pro-
liferation in lymphopenic hosts. In favor of this hypothesis, 
we found similar Vβ TCR usage within CD122lo MP CD8+ 
cells and polyclonal CD8+ T cells undergoing homeostatic 
expansion (Fig. S4, A and B, available at http://www.jem.
org/cgi/content/full/jem.20052495/DC1).
In normal hosts, proliferation to self MHC-I ligands might 
be limited to a small subset of naive CD8+ cells with “above-
average” affi   nity for self. If so, what is the fate of the responding 
CD122lo cells? One possibility is that CD122lo cells resemble 
typical eff  ector cells in having a short lifespan: the cells proliferate 
in brief but most of the cells then die. However, CD122lo MP 
CD8+ cells diff  er from typical eff  ector cells in that they are 
CD25lo and display partial anergy, at least for IFN-γ synthesis. 
More importantly, the transfer studies showed that at a popula-
tion level, purifi  ed CD122lo cells did not die but survived quite 
well in WT hosts, with some of the cells diff  erentiating into 
CD122hi cells. Hence, the data favor a model in which contact 
with self–MHC-I ligands drives CD8+ cells to proliferate and 
then diff  erentiate from semi-activated CD122lo cells into  resting 
CD122hi cells. To maintain homeostasis, cell expansion here is 
presumably balanced by an equivalent rate of cell death, but 
how such immunoregulation is controlled is unclear. It is also 
a mystery that diff  erentiation into CD122hi cells causes CD8+ 
cells to lose their MHC-I dependency. Future studies will be 
required to resolve these issues.
MATERIALS AND METHODS
Mice. C57BL/6 (B6), Thy1.1 (B6.PL), CD122-defi  cient (CD122–/–), and 
γc-defi  cient (γc
–/–) mice, all on a B6 background, were purchased from The 
Jackson Laboratory. Db–/– K b–/– β2M–/– MHC-I–defi  cient mice on a B6 
background (16) were provided by R. Ahmed (Emory University, Atlanta, 
GA) and maintained in our animal facility. IL-15–defi  cient (IL-15–/–) mice 
(13) and IL-7 tg mice (14) were maintained in our animal facility. All mice 
were housed under specifi  c pathogen-free conditions at The Scripps Re-
search Institute and used at 3–6 mo of age. Experiments involving the use of 
animals were approved by the Institutional Animal Care and Use Commit-
tee at The Scripps Research Institute.
Flow cytometry and cell sorting. Cell suspensions of spleen or pooled 
(inguinal, axillary, cervical, and mesenteric) LNs were prepared according to 
standard protocols and stained for FACS analysis or sorting using PBS 
  containing 1% FCS and 2 mM EDTA with the following mAbs (from BD 
Biosciences unless otherwise stated): PerCP-Cy5.5–conjugated anti-CD3 
(145-2C11); Alexa Fluor 405–conjugated anti-CD4 (RM4-5; Caltag 
  Laboratories); PerCP-Cy5.5– or APC-Cy7–conjugated anti-CD8α (53-6.7); 
PE-conjugated anti-CD8β (H35-17.2); FITC-conjugated anti-CD25 
(PC61.5); PE-conjugated anti-CD43 (1B11); APC-conjugated anti-CD44 
(IM7; eBioscience); FITC- or PE-conjugated anti-CD62L (MEL-14); 1824  MHC-I–DEPENDENT MEMORY PHENOTYPE CD8+ SUBSET | Boyman et al.
FITC-  conjugated anti-CD69 (H1.2F3); APC-conjugated anti-CD90.1 
(HIS51; eBioscience); FITC- or PE-conjugated anti-CD122 (TM-β1 or 
  alternatively 5H4); PE-conjugated anti-CD127 (SB/14); and PE-conjugated 
anti-CD132 (4G3). For staining of the intracellular markers Bcl-2 and BrdU, 
the Bcl-2 reagent set containing FITC-conjugated anti–Bcl-2 mAb (3F11) 
or FITC-conjugated isotype-matched control mAb and the FITC BrdU 
fl  ow kit (both from BD Biosciences) were used, respectively, according to 
standard protocols (22). In brief, cells were stained for cell surface markers, 
fi  xed using 2% paraformaldehyde, and permeabilized using saponin before 
intracellular staining. Flow cytometry samples were analyzed using a 
BD LSR II digital fl  ow cytometer. For determining Vβ TCR usage, the 
Vβ TCR Screening Panel from BD Biosciences was used according to the 
manufacturer’s recommendation.
Measurement of cell turnover in vivo. Proliferation of cells in vivo was 
measured using dilution of CFSE-labeled cells (13) or incorporation of BrdU 
(0.8 mg/ml) given in the drinking water (22). CFSE staining was performed 
as follows: cells were resuspended in PBS containing 1% FCS at 10–20 × 106 
cells/ml and stained with 1 μl of 5 mM Vybrant CFDA SE Cell Tracer kit 
(Invitrogen) per milliliter of cell suspension for 10 min at 37°C, and then 
washed twice with ice-cold PBS containing 1% FCS. BrdU staining was 
performed as described above.
In vitro stimulation and IFN-𝗄 measurement by ELISA. Spleen cells 
from normal B6 mice were sorted by FACS for CD44lo, CD44hi CD122lo, 
and CD44hi CD122hi CD8+ T cells. These purifi  ed CD8+ cell subsets were 
then seeded in a V-bottom 96-well plate in triplicates at 7 × 105 cells/well 
and stimulated with 50 ng/ml PMA and 500 ng/ml ionomycin for 4 h under 
standard culture conditions (37°C, 7% CO2, humidifi  ed atmosphere). Super-
natants were then collected and assayed for IFN-γ by a sandwich ELISA ac-
cording to standard protocols, as described previously (39). In brief, culture 
supernatants were diluted serially in PBS and added to fl  at-bottom 96-well 
plates coated with a purifi  ed mAb specifi  c for IFN-γ (XMG1.2; eBioscience). 
Known concentrations of recombinant murine IFN-γ were used as 
standards. After incubation for 2 h at 37°C, the plates were washed and bio-
tinylated mAb (R4-6A2; eBioscience) was added for 1 h at 37°C. After 
washing again, streptavidin-conjugated horseradish peroxidase was added for 
1 h at room temperature. The samples were then developed using the sub-
strate O-phenylenediamine (Sigma-Aldrich) and, after stopping the reaction 
with 2 N H2SO4, analyzed with an ELISA reader (Spectramax Plus 384; 
Molecular Devices).
Adoptive transfer of purifi  ed CD8+ T cell subsets. Pooled LN cells 
from Thy1.1-marked WT or IL-7 tg mice were surface stained for CD122, 
CD8β, and CD44 and sorted using a Becton Dickinson FACS Aria. Purities 
of FACS-sorted CD8+ T cell subsets were >99% for CD44lo, 88–90% for 
CD44hi CD122lo, and >99% for CD44hi CD122hi. CD8+ T cell subsets 
were then transferred i.v. at 1.5 × 106 cells/mouse to Thy1.2-marked WT 
mice and left for 7 d before mice were killed. IL-7 tg mice were used in 
some experiments as they contained higher numbers of total spleen and LN 
cells enriched for CD44hi CD8+ T cells (14), which, divided into CD122lo 
and CD122hi cells, were indistinguishable from the corresponding subsets in 
WT mice by all parameters tested (Fig. 3 and unpublished data). For experi-
ments using adoptive transfer of purifi  ed CD44hi T cells, pooled LN cells 
from Thy1.1-marked WT or IL-7 tg mice were FACS sorted (yielding 
a purity of >98%), labeled with CFSE where indicated, and transferred i.v. 
at the indicated cell numbers/mouse to sublethally irradiated (750 cGy) 
Thy1.2-marked WT or MHC-I–/– mice. 7 d after transfer, mice were killed 
and analyzed by fl  ow cytometry.
Adoptive transfer of purifi  ed CD8+ T cells from CD122–/– hosts. For 
experiments involving whole T cells, pooled LN cells from CD122–/– mice 
were subjected to complement-mediated killing by treating cell suspension 
with anti–heat-stable antigen mAb (J11d) and anti–MHC-II mAb (28-16-8s) 
plus complement (40). Purity was routinely >95%. Cells were then labeled 
with CFSE (see above) and injected i.v. at 2–3 × 106 T cells per recipient. 
Recipients were irradiated with 750 cGy 6–8 h before adoptive transfer. For 
CD122–/– CD8+ T cell subsets, LN cells from CD122–/– mice were prepared 
as described above and subsequently sorted by FACS. The purity of FACS-
sorted CD8+ CD44hi cells was  99%. Alternatively, CD122–/– CD8+ cells 
were enriched for CD44hi cells by negative depletion of LN cells using 
MACS CD8+ T cell isolation kit (Miltenyi Biotec) in combination with 
biotinylated anti-CD62L mAb (MEL-14). In brief, pooled LN cells from 
CD122–/– mice were incubated with biotinylated mAbs against CD4 (L3T4), 
CD45R (B220), CD49b (DX5), CD11b (Mac-1), Ter-119, and CD62L, 
followed by incubation with anti-biotin MicroBeads and negative depletion 
of labeled cells. Typical purities of sorted cells were  90%. CD122–/– CD44hi 
CD8+ cells were then CFSE labeled and adoptively transferred i.v. at 2–3 × 106 
cells per host. Recipient mice underwent split-dose irradiation of 600 cGy 
2 wk before plus 600 cGy 6–8 h before adoptive transfer.
Mixed BM radiation chimeras. BM cells were obtained from Thy1.1-
marked WT or MHC-I–/– mice, and mature B, T, and MHC-II–expressing 
cells were depleted using mAbs against heat-stable antigen (J11d), Thy1.1 
(T24), CD4 (RL172), CD8 (3.168), and MHC-II (28-16-8s) plus comple-
ment. Contamination of purifi  ed BM cells with mature B, T, or MHC-II–
expressing cells was <2%. Recipient Thy1.2-marked WT or MHC-I–/– mice 
were irradiated at 1,300 cGy before i.v. injection of 5–10 × 106 purifi  ed BM 
cells. Recipients were given antibiotics in their drinking water for the fi  rst 
3–4 wk and left for 3–4 mo to allow for de novo T cell generation. Donor 
BM-derived T cells were then identifi  ed by Thy1.1 and purifi  ed using mAbs 
against heat-stable antigen (J11d), Thy1.2 (J1j.10), and MHC-II (28-16-8s) 
plus complement as described above. 2–3 × 106 Thy1.1 T cells were in-
jected i.v. into Thy1.2 WT or MHC-I–/– mice, which had been depleted of 
NK cells using anti-NK1.1 ascites fl  uid (PK136) on days −3 and −1 before 
adoptive transfer and every other day thereafter.
Online supplemental material. Fig. S1 shows expression of CD25, 
CD122, γc, CD43, CD44, CD62L, CD69, and CD127 on antigen-specifi  c 
naive, eff  ector, and memory CD8+ T cells during a response to lymphocytic 
choriomeningitis virus. Fig. S2 shows that, in vitro, IL-15 leads to down-
regulation of CD122 on MP CD8+ cells without aff  ecting their CD62L levels. 
Fig. S3 shows that CD8+ MP cells from CD122–/– mice are comparable to 
the CD122lo subset of MP CD8+ cells from WT mice. Fig. S4 shows Vβ 
TCR usage within CD8+ T cell subsets and within CD8+ T cells under-
going homeostatic expansion. Figs. S1–S4 are available at http://www.jem.
org/cgi/content/full/jem.20052495/DC1.
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